Lymphadenectomy for bladder cancer: indications and controversies.
Détails
ID Serval
serval:BIB_2C9416C4767A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Lymphadenectomy for bladder cancer: indications and controversies.
Périodique
The Urologic clinics of North America
ISSN
1558-318X (Electronic)
ISSN-L
0094-0143
Statut éditorial
Publié
Date de publication
11/2011
Peer-reviewed
Oui
Volume
38
Numéro
4
Pages
397-405, v
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Pelvic lymph node dissection (PLND) at the time of cystectomy remains the most accurate method of staging and can have a positive impact on cancer control, and there is general agreement as to its necessity at the time of surgery. There is, however, a lack of consensus regarding the terminology of PLND and controversy concerning the optimal extent of lymph node dissection, especially because recent investigations have suggested a survival benefit with extended PLND.
Mots-clé
Biopsy, Needle, Carcinoma, Transitional Cell/mortality, Carcinoma, Transitional Cell/pathology, Carcinoma, Transitional Cell/surgery, Cystectomy/methods, Cystectomy/mortality, Humans, Immunohistochemistry, Lymph Node Excision/standards, Lymph Node Excision/trends, Lymph Nodes/pathology, Lymph Nodes/surgery, Male, Neoplasm Invasiveness, Neoplasm Recurrence, Local/mortality, Neoplasm Recurrence, Local/pathology, Neoplasm Recurrence, Local/surgery, Neoplasm Staging, Pelvis/pathology, Pelvis/surgery, Prognosis, Risk Assessment, Survival Analysis, Urinary Bladder Neoplasms/mortality, Urinary Bladder Neoplasms/pathology, Urinary Bladder Neoplasms/surgery
Pubmed
Web of science
Création de la notice
08/01/2021 15:24
Dernière modification de la notice
09/01/2021 6:26